Bill Title: Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Spectrum: Slight Partisan Bill (Democrat 7-3)

Status: (Passed) 2016-12-05 - Approved P.L.2016, c.73. [S2024 Detail]

Text: Latest bill text (Chaptered) [HTML]

---

Sponsors

Name	Type	Sponsorship	District	Financial	Encyclopedia	Biography
Senator Fred Madden [D]	Primary	Sponsored Bills	SD-004	FollowTheMoney	Ballotpedia	VoteSmart
Senator Steven Oroho [R]	Primary	Sponsored Bills	SD-024	FollowTheMoney	Ballotpedia	VoteSmart
Representative Timothy Eustace [D]	Primary	Sponsored Bills	HD-038	FollowTheMoney	Ballotpedia	VoteSmart
Representative Erik Peterson [R]	Primary	Sponsored Bills	HD-023	FollowTheMoney	Ballotpedia	VoteSmart
Representative Herbert Conaway [D]	Primary	Sponsored Bills	HD-007	FollowTheMoney	Ballotpedia	VoteSmart
Senator Raj Mukherji [D]	Primary	Sponsored Bills	SD-032	FollowTheMoney	Ballotpedia	VoteSmart
Representative Daniel Benson [D]	Primary	Sponsored Bills	HD-014	FollowTheMoney	Ballotpedia	VoteSmart
Senator Angela Mcknight [D]	Primary	Sponsored Bills	SD-031	FollowTheMoney	Ballotpedia	VoteSmart
Senator Declan O'Scanlon [R]	Cosponsor	Sponsored Bills	SD-013	FollowTheMoney	Ballotpedia	VoteSmart
Representative Nancy Pinkin [D]	Cosponsor	Sponsored Bills	HD-018	FollowTheMoney	Ballotpedia	VoteSmart

Social Comments on NJ S2024